Literature DB >> 19186253

Rescuing proteins of low kinetic stability by chaperones and natural ligands phenylketonuria, a case study.

Aurora Martinez1, Ana C Calvo, Knut Teigen, Angel L Pey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19186253     DOI： 10.1016/S0079-6603(08)00603-X

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN： 1877-1173            Impact factor:   3.622


× No keyword cloud information.
  10 in total

Review 1.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

2.  Folding dynamics of phenylalanine hydroxylase depends on the enzyme's metallation state: the native metal, iron, protects against aggregate intermediates.

Authors:  Aristobulo Loaiza; Judith A Ronau; Alexander Ribbe; Lia Stanciu; John W Burgner; Lake N Paul; Mahdi M Abu-Omar
Journal:  Eur Biophys J       Date:  2011-06-07       Impact factor: 1.733

3.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

4.  Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type.

Authors:  Ana Jorge-Finnigan; Sandra Brasil; Jarl Underhaug; Pedro Ruíz-Sala; Begoña Merinero; Ruma Banerjee; Lourdes R Desviat; Magdalena Ugarte; Aurora Martinez; Belén Pérez
Journal:  Hum Mol Genet       Date:  2013-05-13       Impact factor: 6.150

5.  Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses.

Authors:  Angel L Pey; Maristella Maggi; Giovanna Valentini
Journal:  J Inherit Metab Dis       Date:  2014-05-17       Impact factor: 4.982

Review 6.  Second-Generation Pharmacological Chaperones: Beyond Inhibitors.

Authors:  My Lan Tran; Yves Génisson; Stéphanie Ballereau; Cécile Dehoux
Journal:  Molecules       Date:  2020-07-09       Impact factor: 4.411

7.  A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.

Authors:  Helene J Bustad; Karen Toska; Caroline Schmitt; Marta Vorland; Lars Skjærven; Juha P Kallio; Sylvie Simonin; Philippe Letteron; Jarl Underhaug; Sverre Sandberg; Aurora Martinez
Journal:  Mol Ther       Date:  2019-12-04       Impact factor: 11.454

Review 8.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

9.  The influence of chemical chaperones on enzymatic activity under thermal and chemical stresses: common features and variation among diverse chemical families.

Authors:  Michal Levy-Sakin; Or Berger; Nir Feibish; Noa Sharon; Lee Schnaider; Guy Shmul; Yaniv Amir; Ludmila Buzhansky; Ehud Gazit
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

10.  Modulation of Human Phenylalanine Hydroxylase by 3-Hydroxyquinolin-2(1H)-One Derivatives.

Authors:  Raquel R Lopes; Catarina S Tomé; Roberto Russo; Roberta Paterna; João Leandro; Nuno R Candeias; Lídia M D Gonçalves; Miguel Teixeira; Pedro M F Sousa; Rita C Guedes; João B Vicente; Pedro M P Gois; Paula Leandro
Journal:  Biomolecules       Date:  2021-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.